A groundbreaking study published in Nature Communications has unveiled an intricate molecular mechanism by which the post-translational modification of superoxide dismutase 1 (SOD1) through lactylation drastically impairs its enzymatic function, setting off a cascade of cellular dysfunction leading to intervertebral disc degeneration (IVDD). This research, conducted by Zhang, Y., Zhai, Y., Liu, C., and colleagues, presents fundamentally new insights into how metabolic byproducts influence protein behavior at the structural level, driving pathological changes in the spinal disc microenvironment.
SOD1 is a cornerstone antioxidant enzyme responsible for catalyzing the dismutation of superoxide radicals, a reactive oxygen species (ROS), into molecular oxygen and hydrogen peroxide. This enzymatic activity is critical for cellular redox homeostasis, particularly in tissues like the intervertebral disc which are prone to oxidative stress. The novel finding that lactylation—an enzymatic addition of a lactate group onto lysine residues—can disrupt SOD1’s conformation and thereby its enzymatic function offers a fresh perspective on the molecular pathogenesis of IVDD, a debilitating condition often associated with chronic back pain and mobility impairment.
The researchers employed a combination of advanced biophysical and biochemical methodologies, including mass spectrometry-based proteomics, cryo-electron microscopy, and enzymatic activity assays, to characterize the extent and impact of SOD1 lactylation at the molecular level. Their data convincingly show that lactylation induces subtle yet critical conformational changes that alter the enzyme’s active site geometry and metal cofactor coordination, directly diminishing its catalytic efficiency. These structural alterations impede SOD1’s ability to neutralize ROS, thus amplifying oxidative damage within disc cells.
Importantly, through in vitro models of human nucleus pulposus cells—the central cellular component of the intervertebral disc—the study demonstrated that increased lactate levels, often a byproduct of altered disc metabolism under stress or injury, promote extensive lactylation of SOD1. This post-translational modification correlates with measurable declines in enzymatic activity, increased ROS accumulation, and subsequent cellular senescence markers. These findings suggest a mechanistic link between metabolic dysregulation, oxidative stress, and the cellular aging processes implicated in IVDD.
Delving deeper into the pathological consequences, the research highlights how the impaired antioxidant defense exacerbates extracellular matrix degradation within the disc. Matrix components like aggrecan and collagen-II, critical for maintaining disc structural integrity and hydration, progressively break down in the lactylation-modified environment. This degradation further compromises disc biomechanics, fostering a vicious cycle of degeneration where declining matrix quality fuels metabolic stress and vice versa.
Moreover, the study provides compelling evidence that interrupting the lactylation pathway can restore SOD1 function and mitigate degenerative changes. Using small molecule inhibitors of lactyl-CoA synthetase, which is essential for generating the lactyl group donor, the researchers effectively reduced SOD1 lactylation in cellular and organotypic disc cultures. This intervention rescued antioxidant capacity, reduced ROS levels, and protected matrix components, offering a promising therapeutic avenue to halt or even reverse early-stage IVDD.
Beyond the immediate clinical implications, this work significantly advances our understanding of how metabolic shifts intersect with protein chemistry to alter cell fate in complex tissues. Lactylation, a relatively recently discovered post-translational modification, is emerging as a crucial regulator in pathophysiology, linking metabolic flux to epigenetic and proteomic changes. The demonstration that lactylation directly impairs an essential antioxidant enzyme underscores the broader impact such modifications may have in age-related and degenerative diseases.
The research further contextualizes the role of altered disc metabolism in IVDD. Accumulating evidence has tied disc degeneration to hypoxia-induced metabolic reprogramming, where glycolysis dominates, leading to elevated lactate production. The current study elegantly connects this metabolic phenotype to specific biochemical consequences on protein function, thereby providing a mechanistic explanation for how metabolic shifts translate into structural tissue degradation and clinical symptoms.
From a structural biology perspective, the team’s use of cryo-EM to resolve the conformational changes in SOD1 is a remarkable technical achievement. It details how lactylation causes precise alterations in loop regions and metal-binding sites, destabilizing the catalytic core. This structural insight not only clarifies the inhibition mechanism but also lays the groundwork for rational drug design targeting lactylation sites or stabilizing SOD1 conformations resistant to modification.
The investigation also extends into in vivo models of disc degeneration, where elevated lactylation of SOD1 correlates with worsened histopathological scores and mechanical dysfunction. Modulating lactate metabolism or inhibiting lactylation enzymatically improved disc parameters and animal mobility, validating the pathway as a credible target for therapeutic development in humans.
This study arrives at a crucial moment when the burden of spinal degenerative diseases is rising globally due to aging populations and sedentary lifestyles. Current treatments for IVDD are largely palliative, focusing on symptom management rather than interrupting the molecular drivers of degeneration. By identifying a previously unrecognized regulatory mechanism disrupting a key antioxidant defense, these findings pave the way for novel interventions aimed at preserving disc health at the molecular level.
The interdisciplinary approach combining molecular biology, structural biochemistry, metabolic profiling, and in vivo models exemplifies the power of integrative science in unraveling complex disease mechanisms. It also highlights how advancing technologies like mass spectrometry and cryo-EM can illuminate subtle but pivotal changes in protein modifications with profound pathological outcomes.
Looking forward, this research invites further exploration into the landscape of lactylation beyond SOD1. It prompts questions about how other proteins critical for disc cell survival and matrix maintenance are affected by this modification, potentially broadening the scope of lactylation’s impact in IVDD and related musculoskeletal disorders.
In conclusion, Zhang and colleagues have provided a transformative contribution to our understanding of intervertebral disc degeneration by revealing SOD1 lactylation as a decisive molecular switch that undermines antioxidant defenses and accelerates disc pathology. The insights gained not only deepen our grasp of IVDD’s etiology but also open promising therapeutic avenues focused on metabolic and post-translational modification pathways, heralding a new era in spinal health research and clinical care.
Subject of Research: Molecular mechanisms underlying intervertebral disc degeneration, focusing on the impact of SOD1 lactylation.
Article Title: SOD1 lactylation impairs its enzymatic activity by conformational change to aggravate intervertebral disc degeneration.
Article References:
Zhang, Y., Zhai, Y., Liu, C. et al. SOD1 lactylation impair its enzymatic activity by conformational change to aggravate intervertebral disc degeneration. Nat Commun (2026). https://doi.org/10.1038/s41467-026-69127-3
Image Credits: AI Generated
